<DOC>
	<DOCNO>NCT01666782</DOCNO>
	<brief_summary>The safety immunogenicity high dose influenza vaccine study young patient receive chemotherapy . This study evaluate compare immunogenicity safety high dose influenza standard dose influenza vaccine adult oncology patient young 65 year old receiving chemotherapy .</brief_summary>
	<brief_title>Study Comparing High-Dose Flu Vaccine Standard Vaccine Cancer Patients Less Than 65 Receiving Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . 18 year old less 65 year old 2 . Subjects malignancy must receive chemotherapy 3 . Medically stable 4 . Able understand willingness sign write informed consent 5 . Able comply study procedures 6 . Life expectancy 3 month 7 . Adequate organ function : ANC &gt; 1000/mm3 Platelet &gt; 100,000/uL Creatinine &lt; 2 mg/dL AST ALT &lt; 3 time ULN 1 . Allergy egg 2 . Prior allergy Influenza Vaccine 3 . History GuillainBarre Syndrome 4 . Current febrile illness 5 . Other immunosuppressive disease ( recipient solid organ transplant , uncontrolled HIV ) 6 . Autologous Allogenic Stem Cell Transplant year 7 . Current immunotherapy immunochemotherapy last 6 month ( rituximab ofatumumab )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Influenza vaccine</keyword>
	<keyword>Oncology</keyword>
	<keyword>Chemotherapy</keyword>
</DOC>